JW Lifescience Corporation (KRX:234080)

South Korea flag South Korea · Delayed Price · Currency is KRW
12,970
-130 (-0.99%)
Apr 29, 2026, 1:49 PM KST
14.27%
Market Cap 202.85B
Revenue (ttm) 257.83B
Net Income (ttm) 28.61B
Shares Out 15.48M
EPS (ttm) 1,847.00
PE Ratio 7.09
Forward PE n/a
Dividend 500.00 (3.86%)
Ex-Dividend Date Mar 31, 2026
Volume 17,445
Average Volume 32,230
Open 13,100
Previous Close 13,100
Day's Range 12,940 - 13,120
52-Week Range 11,250 - 15,580
Beta 0.33
RSI 55.61
Earnings Date May 14, 2026

About JW Lifescience

JW Lifescience Corporation provides national infusion solutions in South Korea and internationally. The company offers basic intravenous fluid that comprises water, electrolytes, and glucose; nutrient infusion solution that consist of nutrients, such as amino acids, lipids, proteins, vitamins, and minerals; and special infusion solutions. The company was formerly known as JW Co. Ltd. and changed its name to JW Lifescience Corporation in April 2011. JW Lifescience Corporation was founded in 1994 and is based in Dangjin-si, South Korea. [Read more]

Sector Healthcare
Founded 1994
Employees 297
Stock Exchange Korea Stock Exchange
Ticker Symbol 234080
Full Company Profile

Financial Performance

In 2025, JW Lifescience's revenue was 257.83 billion, an increase of 15.89% compared to the previous year's 222.48 billion. Earnings were 28.61 billion, a decrease of -34.97%.

Financial Statements

News

There is no news available yet.